ERBB2 and breast carcinoma: We tested several doses of DIM and Herceptin at different time points (data not shown) and found that treatment of SKBR3 and MDA-MB-468 breast cancer cells with 15 μM DIM for 72 h caused 40–60% growth inhibition which is irrespective of HER-2/neu status.